Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Effects of Social and Economic Deprivation on Cancer Mortality

Cancer Glossary

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

What Causes Cancer?

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

The Effects of Cancer on Family Life

Cancer Diagnosis

The Cancer Cell Surface Proteome as a Therapeutic Target

Secondary Lung Cancer

Cancer Epidemiology

Caring for a Loved One with Cancer

See more featured articles »

Cancer Classification

Hypoxia Markers and Their Importance

Cancer Prognosis

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

CDK9 and Cancer

Cancer Pain

What is Cancer?

Cancer Management

Targeted Cancer Therapies

Cancer Pain Management

Is Cancer a Metabolic Disorder?

Why are Cancer Cell Lines Useful?

Insight into Cancer Vaccines

What is Immunochemotherapy?

Living with Cancer Pain

What is the Tumor Microenvironment?

TARDIS: The Improved Method of Detecting Breast Cancer

What is Tumorigenesis?

What Role do Biobanks Play in Cancer Research?

Using Biomarkers to Detect Cancer

British Pioneers in Cancer Biology

Myc Mutations and Cancer

Hot vs Cold: the differences between tumor types

Cancer Prevention: Lowering your Risk

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

What is Merkel Cell Carcinoma?

Acidosis and Tumor Progression

Secondary Brain Cancer

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cutaneous Manifestations of Internal Malignancy

Extracellular Vesicles as Floating Cancer Biomarkers

Overview of Cell Viability and Cytotoxicity

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer History

Cancer Pathophysiology

Pediatric Cancer

Cancer Research

Insights into Oncofertility

Microfluidic cancer treatment screen combined with flow cytometry

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

The Biochemistry of Breast Cancer Screening

Transforming Cancer Care through Genomic Testing

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Investigating the Molecular Mechanisms of Cancer

What is Cancer of Unknown Primary?

Cancer Symptoms

Cancer Screening Considerations: Balancing the Benefits and Risks

Assay for Monitoring and Treating Malignant Brain Tumors

Metastatic Migration in Cancer may be Influenced by Metabolism

Latest Cancer News and Research

New hormone receptor strategy offers targeted treatment for lupus

Researchers at the University of California, Riverside and City of Hope have identified a new strategy for treating systemic lupus erythematosus (SLE), or lupus, an autoimmune disease in which the immune system attacks healthy tissues.

2 Nov 2026

New study evaluates quantum machine learning for lung cancer prediction

Developing reliable machine learning models for healthcare can be challenging when only small datasets are available. This challenge motivates research into whether quantum computing approaches can learn useful patterns from limited symptom and risk-factor data.

2 Nov 2026

Aspirin fails to prevent recurrence after surgery for colorectal cancer liver metastases

Colorectal cancer is one of the most common cancers in Norway, which also has one of the highest incidence rates in the world.

2 Nov 2026

New strategy exploits a hidden genetic vulnerability in multiple cancers

Researchers have found a surprisingly common vulnerability in a broad variety of cancers and have begun designing drug compounds to exploit it, in a study led by investigators at Weill Cornell Medicine.

2 Nov 2026

Targeting EGFR signaling to reduce mucus overproduction in lung diseases

Airway mucus is part of innate lung defense, but when production overwhelms clearance, it obstructs airflow and worsens disease.

2 Nov 2026

Australian Health Data Evidence Network formed to standardize real world medical records

Australia is missing an opportunity in how to improve data-driven healthcare.

2 Nov 2026

Extreme heat and cold hit some people far harder, and it's not just about illness

Researchers analysing 285,444 adults in Finland and the UK found that excess mortality associated with extreme heat and cold was more than tenfold higher among people with both pre-existing medical conditions and socioeconomic disadvantage than among those with neither or only one vulnerability. Climate modelling suggested that warming from approximately 1°C to 4°C could increase the proportion of deaths attributable to extreme temperatures from around 1% to more than 5% in both countries.

1 Nov 2026

New strategy identified for overcoming resistance to KRAS-targeted cancer therapies

Researchers at Roswell Park Comprehensive Cancer Center have identified a promising strategy for overcoming one of the biggest challenges facing KRAS-targeted cancer therapies: treatment resistance.

30 Oct 2026

Nanoscale particle shows potential as customizable delivery vehicle for personalized cancer vaccines

A nanoscale particle with a unique structure, developed at MIT, holds potential as a customizable delivery vehicle for personalized cancer vaccines.

30 Oct 2026

Light-activated molecular cages offer precise control over protein degradation

Researchers have created a molecular "cage" that keeps protein-degrading drug molecules inactive until they are exposed to low-energy red light.

30 Oct 2026

Space-grown organoids better replicate aggressive glioblastoma tumors

Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer.

30 Oct 2026

Immunotherapy reshapes immune cell interactions in melanoma-affected lymph nodes

A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them.

30 Oct 2026

Hyperactive cancer-promoting proteins help tumor cells evade immune attack

The immune system may recognize a cancer cell and still fail to destroy it. Researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting proteins, were associated with genomic instability that may make cancer cells more recognizable to the immune system, while also increasing PD-L2, which helps the cells suppress T-cell attack.

30 Oct 2026

Incisionless brain procedure eliminates Parkinson's tremors for air force veteran

To the untrained eye, a "ham" radio may look like a simple device. However, inside its casing, dozens of delicate wires and tiny elements perform distinct yet connected functions to deliver messages to a vast network of operators around the world.

30 Oct 2026

Mayo Clinic enters new medical era with precure research

Mayo Clinic researchers are uncovering the earliest shifts in disease biology - long before symptoms appear - revealing how disease takes root and opening new possibilities to identify, predict and potentially prevent disease before symptoms develop.

30 Oct 2026

Targeting specific enzyme reverses radiation-induced immune suppression in cancer

Researchers at the University of Chicago identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them.

30 Oct 2026

Targeting ANO6 protein weakens pancreatic cancer and boosts immunity

Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular protein, called anoctamin 6 (ANO6).

30 Oct 2026

Tailoring prostate cancer radiotherapy to body clock could cut long-term side effects

A study by Leicester researchers shows that the timing of radiotherapy treatment may be as important as how it is given for prostate cancer patients.

30 Oct 2026

Platelet hyperactivity drives glioblastoma progression and deep vein thrombosis

New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence immune activity. The overactive platelets in people with glioblastoma slow the activity of cancer-fighting T cells, which can contribute to tumor growth and cancer progression.

30 Oct 2026

Research addresses critical gap in nonverbal palliative nursing decisions

Flinders University research published in the Journal of Advanced Nursing has examined how specialist palliative care nurses navigate these complex decisions, and found they draw on clinical expertise, ethical judgement, close observation and family engagement to guide care during a patient's final days.

30 Oct 2026